BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25203777)

  • 1. Discovery of potential and selective COX-1 inhibitory leads using pharmacophore modelling, in silico screening and in vitro evaluation.
    Balaji B; Hariharan S; Shah DB; Ramanathan M
    Eur J Med Chem; 2014 Oct; 86():469-80. PubMed ID: 25203777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents.
    Palkar MB; Singhai AS; Ronad PM; Vishwanathswamy AH; Boreddy TS; Veerapur VP; Shaikh MS; Rane RA; Karpoormath R
    Bioorg Med Chem; 2014 May; 22(10):2855-66. PubMed ID: 24751552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of novel N-phenylnicotinamides as selective cyclooxygenase-1 inhibitors.
    Shi L; Li ZL; Yang Y; Zhu ZW; Zhu HL
    Bioorg Med Chem Lett; 2011 Jan; 21(1):121-4. PubMed ID: 21144750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN; Chen QH; Knaus EE
    J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Bridged' stilbene derivatives as selective cyclooxygenase-1 inhibitors.
    Handler N; Brunhofer G; Studenik C; Leisser K; Jaeger W; Parth S; Erker T
    Bioorg Med Chem; 2007 Sep; 15(18):6109-18. PubMed ID: 17604631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors.
    Vitale P; Tacconelli S; Perrone MG; Malerba P; Simone L; Scilimati A; Lavecchia A; Dovizio M; Marcantoni E; Bruno A; Patrignani P
    J Med Chem; 2013 Jun; 56(11):4277-99. PubMed ID: 23651359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators.
    Kalgutkar AS; Kozak KR; Crews BC; Hochgesang GP; Marnett LJ
    J Med Chem; 1998 Nov; 41(24):4800-18. PubMed ID: 9822550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A; Najafnia L; Daraee B; Dadrass OG; Hedayati M
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5634-7. PubMed ID: 17822894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents.
    Velázquez C; Rao PN; McDonald R; Knaus EE
    Bioorg Med Chem; 2005 Apr; 13(8):2749-57. PubMed ID: 15781386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory mode of 2-acetoxyphenyl alkyl sulfides against COX-1 and COX-2: QSAR analyses.
    Jain HK; Mourya VK; Agrawal RK
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5280-4. PubMed ID: 16908140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-alpha production.
    Chen CS; Tan CM; Huang CH; Chang LC; Wang JP; Cheng FC; Chern JW
    Bioorg Med Chem; 2010 Jan; 18(2):597-604. PubMed ID: 20056549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of new 4-phenylpyrimidine-2(1H)-thiones and their potency to inhibit COX-1 and COX-2.
    Seebacher W; Faist J; Presser A; Weis R; Saf R; Kaserer T; Temml V; Schuster D; Ortmann S; Otto N; Bauer R
    Eur J Med Chem; 2015 Aug; 101():552-9. PubMed ID: 26197159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pyrazolopyrimidine derivatives targeting COXs and iNOS enzymes; design, synthesis and biological evaluation as potential anti-inflammatory agents.
    Abdelazeem AH; Abdelatef SA; El-Saadi MT; Omar HA; Khan SI; McCurdy CR; El-Moghazy SM
    Eur J Pharm Sci; 2014 Oct; 62():197-211. PubMed ID: 24907682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of 2-substituted-1-naphthol derivatives on cyclooxygenase I and II.
    Kongkathip B; Sangma C; Kirtikara K; Luangkamin S; Hasitapan K; Jongkon N; Hannongbua S; Kongkathip N
    Bioorg Med Chem; 2005 Mar; 13(6):2167-75. PubMed ID: 15727869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and SAR/3D-QSAR studies on the COX-2 inhibitory activity of 1,5-diarylpyrazoles to validate the modified pharmacophore.
    Singh SK; Saibaba V; Rao KS; Reddy PG; Daga PR; Rajjak SA; Misra P; Rao YK
    Eur J Med Chem; 2005 Oct; 40(10):977-90. PubMed ID: 15961192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
    Tewari AK; Singh VP; Yadav P; Gupta G; Singh A; Goel RK; Shinde P; Mohan CG
    Bioorg Chem; 2014 Oct; 56():8-15. PubMed ID: 24893208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore modeling for COX-1 and -2 inhibitors with LigandScout in comparison to Discovery Studio.
    Temml V; Kaserer T; Kutil Z; Landa P; Vanek T; Schuster D
    Future Med Chem; 2014; 6(17):1869-81. PubMed ID: 25495981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example.
    Rollinger JM; Haupt S; Stuppner H; Langer T
    J Chem Inf Comput Sci; 2004; 44(2):480-8. PubMed ID: 15032527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspective assessment of COX-1 and COX-2 selectivity of nonsteroidal anti-inflammatory drugs from clinical practice: use of genetic function approximation.
    Zambre AP; Ganure AL; Shinde DB; Kulkarni VM
    J Chem Inf Model; 2007; 47(2):635-43. PubMed ID: 17256838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study.
    Abdel-Aziz AA; ElTahir KE; Asiri YA
    Eur J Med Chem; 2011 May; 46(5):1648-55. PubMed ID: 21388719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.